These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Undetectable prostate-specific antigen response with bicalutamide withdrawal phenomenon.
    Author: El-Gabry EA, Strup SE, Gomella LG.
    Journal: Tech Urol; 2000 Sep; 6(3):221-2. PubMed ID: 10963494.
    Abstract:
    Several reports have described the antiandrogen withdrawal syndrome with various nonsteroidal antiandrogen agents. To our knowledge, there have been no reports describing a durable undetectable prostate-specific antigen (PSA) response with discontinuation of the antiandrogen agent bicalutamide (Casodex, Zeneca, Wilmington, DE, U.S.A.). We report a case in which a decline of serum PSA to undetectable levels was achieved with bicalutamide discontinuation.
    [Abstract] [Full Text] [Related] [New Search]